STRATEC Biomedical Systems AG / Half Year Results/Preliminary Results 24.07.2008 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- STRATEC publishes preliminary figures for first half of 2008 financial year Birkenfeld, July 24, 2008 The Board of Management of STRATEC Biomedical Systems AG, which is listed in the Prime Standard, hereby announces the preliminary unaudited consolidated figures of the STRATEC Group for the first half of the 2008 financial year as of June 30, 2008 pursuant to IFRS (International Financial Reporting Standards) and in accordance with Section 15 of the German Securities Trading Act (WpHG).<pre> Key Figures (EUR 000s) 01.01.- 06.30.2008 01.01.- 06.30.2007 Change Sales 29,549 34,098 -13.3% Gross performance 32,103 34,625 -7.3% EBITDA 6,028 6,993 -13.8% EBIT 4,874 5,897 -17.3% EBT 5,059 5,907 -14.4% Consolidated net income 3,873 4,185 -7.5% Earnings per share (EUR) 0.34 0.37 -8.1%</pre> Including temporary employees, the STRATEC Group had a total of 267 employees as of June 30, 2008 (previous year: 256). --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Two major development and supply agreements were signed in the first six months of the current financial year. Projects currently underway are developing well on schedule, although we also witnessed acquisition-related delays in outbound products being called up by one of our most important customers. This resulted in a consolidation in sales and earnings during the period under report which was within our range of expectations already published. The key figures published by the company are comparable with those for the strong first half of 2007, which was only marginally affected by the aforementioned delays in product call-ups. Based on the current, unchanged acceptance forecasts provided by our customers, we expect to generate sales of between Euro 78 million and Euro 82 million and earnings before taxes (EBIT) of between Euro 16.2 million and Euro 18.2 million for the 2008 financial year. The long-term growth in our company is based on a large number of development and supply contracts already agreed. The development status of existing cooperation projects, as well as new customer orders currently being initiated, give grounds to expect an ongoing positive business performance. The extensive interim report will be available for downloading from our internet site from around 3 p.m. on August 14, 2008. About STRATEC STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange. The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania. Further information can be obtained from: STRATEC Biomedical Systems AG André Loy, Investor Relations Gewerbestr. 37, 75217 Birkenfeld Germany Phone: +49 7082 7916 190 Fax: +49 7082 7916 999 Email: ir@stratec-biomedical.de DGAP 24.07.2008 --------------------------------------------------------------------------- Language: English Issuer: STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland Phone: +49 (0)7082 7916 0 Fax: +49 (0)7082 7916 999 E-mail: info@stratec-biomedical.de Internet: www.stratec-biomedical.de ISIN: DE0007289001 WKN: 728900 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Stuttgart, München, Düsseldorf End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: STRATEC publishes preliminary figures for first half of 2008 financial year
| Source: EQS Group AG